MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/diagnostics16142237

Медицинская библиотека · Diagnostics (Basel, Switzerland) · 2026

Prognostic Value of Dynamic FDG PET-Derived Myocardial Glucose Metabolism in Ischemic Cardiomyopathy with Supportive External Gene-Expression Analysis.

Ko Kuan-Yin, Wang Shan-Ying, Tsai Hao-Yuan, Lee Chien-Lin, Hsu Jung-Cheng, Tu Chung-Ming, Shiau Yu-Chien, Chiu Kuan-Ming, Chen Wen-Pin, Wu Yen-Wen

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

To evaluate whether global myocardial glucose metabolism and its regional heterogeneity, quantified using dynamic 18F-fluorodeoxyglucose positron emission tomography (FDG PET), are associated with cardiovascular outcomes in patients with ischemic cardiomyopathy.

Methods

The analytic cohort included 120 patients with suspected ischemic cardiomyopathy who underwent thallium-201 perfusion single photon emission tomography and dynamic FDG PET. Global myocardial metabolic rate of glucose (MRGlu) and coefficient of variation in FDG uptake were calculated from scar-excluded myocardium. Major adverse cardiac events (MACEs) were assessed over a median follow-up of 2.5 years. Public myocardial gene-expression datasets (GSE116250 and GSE135055) were analyzed to explore glucose metabolism-related transcriptional patterns relevant to the imaging findings.

Results

Fifty-one patients (42.5%) experienced MACEs. Lower global MRGlu was independently associated with improved MACE-free survival (hazard ratio 0.48, 95% confidence interval 0.27-0.87). Among patients with low global MRGlu, a high coefficient of variation predicted favorable outcomes (hazard ratio 0.35, 95% confidence interval 0.18-0.68), indicating beneficial metabolic heterogeneity. Analysis of external gene-expression data demonstrated consistent downregulation of glucose-handling genes in end-stage heart failure across ischemic and dilated etiologies. A higher expression of SLC2A1, HK1, IRS1, and PKM was associated with faster progression to transplantation.

Conclusions

In ischemic cardiomyopathy, dynamic FDG PET-derived quantification of myocardial glucose metabolism provides prognostic information beyond traditional viability assessment. Low global metabolism combined with preserved metabolic heterogeneity helps identify patients with favorable clinical outcomes.

Для цитирования: Ko Kuan-Yin, Wang Shan-Ying, Tsai Hao-Yuan, Lee Chien-Lin, Hsu Jung-Cheng, Tu Chung-Ming, Shiau Yu-Chien, Chiu Kuan-Ming, Chen Wen-Pin, Wu Yen-Wen. Prognostic Value of Dynamic FDG PET-Derived Myocardial Glucose Metabolism in Ischemic Cardiomyopathy with Supportive External Gene-Expression Analysis.. Diagnostics (Basel, Switzerland). 2026. DOI: 10.3390/diagnostics16142237.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.